Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOXI trial
2022-501979-10-00Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 4, randomised trial in mpox comparing Tpoxx with Placebo (2 arms). Primary endpoint: Time to complete lesion resolution. Started Dec 2022; status: completed.
02
Drugs
tecovirimat
03
Conditions
mpox
Beyond the preview
Go deeper on 2022-501979-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501979-10-00.